Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marek Jarema

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Psychiatria Polska|June 12, 2016
Elective cesarean section on psychiatric indications - the phenomenon analysis, report of two cases and psychiatric clinical recommendationsJustyna Holka-Pokorska, Marek Jarema, Artur Stefanowicz, et al.
Psychiatria Polska|June 22, 2015
[Guidelines for the use of second-generation long-acting antipsychotics]Marek Jarema, Adam Wichniak, Dominika Dudek, et al.
Psychiatria Polska|September 4, 2017
Hypersomnia and cognitive impairment in a patient with bipolar disorder - a case reportKatarzyna Szaulińska, Anna Antosik-Wójcińska, Ewa Paszkowska, et al.
Psychiatria Polska|January 12, 2012
[Trazodon--the antidepressant: mechanism of action and its position in the treatment of depression]Marek Jarema, Dominika Dudek, Jerzy Landowski, et al.
Pharmacological Reports : PR|December 3, 2014
Daytime sleepiness and EEG abnormalities in patients treated with second generation antipsychotic agentsLukasz Okruszek, Wojciech Jernajczyk, Aleksandra Wierzbicka, et al.
Journal of Psychiatric Research|June 18, 2011
Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidoneAdam Wichniak, Agnieszka Skowerska, Jolanta Chojnacka-Wójtowicz, et al.
Psychiatria Polska|August 25, 2009
[Sleep quality and daytime sleepiness in schizophrenia spectrum disorders during antipsychotic treatment]Adam Wichniak, Elzbieta Waliniowska, Aleksandra Wierzbicka, et al.
Psychiatria Polska|December 11, 2012
[MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia]Małgorzata Jedrasik-Styła, Agnieszka Ciołkiewicz, Mirella Denisiuk, et al.
Psychiatria Polska|February 27, 2015
[The assessment of chosen psychometric features of B-CATS test battery in schizophrenia - preliminary report]Małgorzata Jędrasik-Styła, Agnieszka Ciołkiewicz, Rafał Styła, et al.
Psychiatria Polska|October 17, 2003
[Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial]Marek Jarema, Marcin Olajossy, Włodzimierz Chrzanowski, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Psychiatria Polska|June 12, 2016
Elective cesarean section on psychiatric indications - the phenomenon analysis, report of two cases and psychiatric clinical recommendationsJustyna Holka-Pokorska, Marek Jarema, Artur Stefanowicz, et al.
Psychiatria Polska|June 22, 2015
[Guidelines for the use of second-generation long-acting antipsychotics]Marek Jarema, Adam Wichniak, Dominika Dudek, et al.
Psychiatria Polska|September 4, 2017
Hypersomnia and cognitive impairment in a patient with bipolar disorder - a case reportKatarzyna Szaulińska, Anna Antosik-Wójcińska, Ewa Paszkowska, et al.
Psychiatria Polska|January 12, 2012
[Trazodon--the antidepressant: mechanism of action and its position in the treatment of depression]Marek Jarema, Dominika Dudek, Jerzy Landowski, et al.
Pharmacological Reports : PR|December 3, 2014
Daytime sleepiness and EEG abnormalities in patients treated with second generation antipsychotic agentsLukasz Okruszek, Wojciech Jernajczyk, Aleksandra Wierzbicka, et al.
Journal of Psychiatric Research|June 18, 2011
Actigraphic monitoring of activity and rest in schizophrenic patients treated with olanzapine or risperidoneAdam Wichniak, Agnieszka Skowerska, Jolanta Chojnacka-Wójtowicz, et al.
Psychiatria Polska|August 25, 2009
[Sleep quality and daytime sleepiness in schizophrenia spectrum disorders during antipsychotic treatment]Adam Wichniak, Elzbieta Waliniowska, Aleksandra Wierzbicka, et al.
Psychiatria Polska|December 11, 2012
[MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia]Małgorzata Jedrasik-Styła, Agnieszka Ciołkiewicz, Mirella Denisiuk, et al.
Psychiatria Polska|February 27, 2015
[The assessment of chosen psychometric features of B-CATS test battery in schizophrenia - preliminary report]Małgorzata Jędrasik-Styła, Agnieszka Ciołkiewicz, Rafał Styła, et al.
Psychiatria Polska|October 17, 2003
[Safety and efficacy of olanzapine versus perphenazine in patients with schizophrenia: results of multicenter, 18-week, double-blind clinical trial]Marek Jarema, Marcin Olajossy, Włodzimierz Chrzanowski, et al.
Pageof 6